Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $728.36 | 47 | 99.1% |
| Education | $6.70 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $234.13 | 24 | $0 (2019) |
| Horizon Pharma plc | $109.43 | 5 | $0 (2018) |
| Bioventus LLC | $81.20 | 3 | $0 (2021) |
| Fidia Pharma USA Inc. | $67.89 | 5 | $0 (2024) |
| Antares Pharma, Inc. | $53.77 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $53.10 | 3 | $0 (2019) |
| DePuy Synthes Sales Inc. | $32.22 | 2 | $0 (2023) |
| Orthofix Medical, Inc. | $24.07 | 1 | $0 (2024) |
| DJO, LLC | $20.71 | 1 | $0 (2017) |
| Bovie Medical Corporation | $18.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.25 | 2 | Orthofix Medical, Inc. ($24.07) |
| 2023 | $60.72 | 4 | DePuy Synthes Sales Inc. ($32.22) |
| 2022 | $38.77 | 2 | Antares Pharma, Inc. ($38.77) |
| 2021 | $31.13 | 1 | Bioventus LLC ($31.13) |
| 2019 | $78.54 | 5 | Ferring Pharmaceuticals Inc. ($33.81) |
| 2018 | $129.29 | 7 | Horizon Pharma plc ($47.19) |
| 2017 | $356.36 | 30 | Ferring Pharmaceuticals Inc. ($177.82) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: OSTEOARTHRITIS | ||||||
| 01/10/2024 | Orthofix Medical, Inc. | Physio-Stim (Device) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 09/26/2023 | DePuy Synthes Sales Inc. | PEAK (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Sports Early Intervention | ||||||
| 06/06/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Sports Early Intervention | ||||||
| 05/18/2023 | Avanos Medical | GENVISC 850 SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/05/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 08/16/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 05/24/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/19/2021 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 12/10/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: ORTHOPEDICS | ||||||
| 11/21/2019 | FIDIA PHARMA USA INC. | Hymovis (Device) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Osteoarthritis | ||||||
| 07/18/2019 | FIDIA PHARMA USA INC. | Hymovis (Device) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Osteoarthritis | ||||||
| 03/26/2019 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: OSTEOARTHRITIS | ||||||
| 02/01/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: ORTHOPEDICS | ||||||
| 12/06/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $12.99 | General |
| Category: Musculoskeletal | ||||||
| 08/24/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: RAYOS | ||||||
| 07/26/2018 | FIDIA PHARMA USA INC. | Hymovis (Device) | Food and Beverage | Cash or cash equivalent | $10.22 | General |
| Category: Osteoarthritis | ||||||
| 02/27/2018 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: PENNSAID | ||||||
| 02/15/2018 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ORTHOPEDICS | ||||||
| 01/18/2018 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| 01/16/2018 | Bioventus LLC | GELSYN 3 (Device) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Not Applicable | ||||||
| 12/07/2017 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: ORTHOPEDICS | ||||||
| 12/07/2017 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: ORTHOPEDICS | ||||||
| 12/05/2017 | Fidia Pharma USA Inc. | Hymovis (Device) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Osteoarthritis | ||||||
| 11/15/2017 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RAYOS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 63 | 227 | $45,735 | $21,000 |
| 2022 | 3 | 57 | 218 | $42,965 | $20,049 |
| 2021 | 4 | 79 | 239 | $49,665 | $21,533 |
| 2020 | 4 | 71 | 192 | $39,125 | $14,892 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 133 | $22,310 | $14,502 | 65.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 39 | $7,475 | $2,970 | 39.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 14 | 44 | $13,200 | $2,300 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,750 | $1,228 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 134 | $21,440 | $14,422 | 67.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 41 | $8,625 | $3,360 | 39.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 16 | 43 | $12,900 | $2,266 | 17.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 119 | $19,040 | $12,905 | 67.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 16 | 48 | $9,775 | $3,693 | 37.8% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 18 | 57 | $17,100 | $3,009 | 17.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,750 | $1,926 | 51.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 98 | $15,680 | $8,674 | 55.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 15 | 38 | $7,245 | $2,546 | 35.1% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 18 | 44 | $13,200 | $2,239 | 17.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,000 | $1,434 | 47.8% |
About Dr. Ghislaine Robert, MD
Dr. Ghislaine Robert, MD is a Sports Medicine healthcare provider based in Redmond, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679598510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ghislaine Robert, MD has received a total of $735.06 in payments from pharmaceutical and medical device companies, with $40.25 received in 2024. These payments were reported across 51 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($728.36).
As a Medicare-enrolled provider, Robert has provided services to 270 Medicare beneficiaries, totaling 876 services with total Medicare billing of $77,474. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Redmond, WA
- Active Since 07/13/2006
- Last Updated 03/12/2015
- Taxonomy Code 2081S0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679598510
Products in Payments
- EUFLEXXA (Device) $234.13
- RAYOS (Drug) $56.65
- NOCDURNA (Drug) $53.77
- SYNVISC-ONE (Device) $53.10
- PENNSAID (Drug) $52.78
- Hymovis (Device) $51.71
- GELSYN 3 (Device) $50.07
- Durolane (Device) $31.13
- Physio-Stim (Device) $24.07
- CMF OL1000 (Device) $20.71
- PEAK (Device) $18.40
- HYMOVIS (Device) $16.18
- ORTHOVISC (Device) $13.82
- GENVISC 850 SODIUM HYALURONATE (Device) $13.50
- Zilretta (Drug) $12.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.